Iva Kapustíková; Matej Maruniak; Ľubica Havranová-Sichrovská; Lukáš Stanzel; Ivan Malík; Eva Sedlárová
Authors place of work:
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava, Bratislava, Slovak Republic
Published in the journal:
Čes. slov. Farm., 2015; 64, 212-214
44<sup>th</sup> Conference drug synthesis and analysis
The acid-base dissociation constant (pKa) is an important physicochemical parameter which affects drug pharmacokinetics and toxicity (ADMET: absorption, distribution, metabolism, excretion, toxicity). The early-obtained information about these drug properties may decrease the costly development process of a compound with poor pharmaceutical prospects1, 2). In the present study, dissociation constants of eight newly synthesized arylethanolamine derivatives, with potential α- and β-adrenolytic properties, are determined.
Determination of pKa using capillary zone electrophoresis is based on the measurement of the effective electrophoretic mobility of studied substances as a function of separation electrolyte pH. This relationship is then fitted by a sigmoidal curve, where pKa is the value of pH in the sigmoid inflection point. pKa values obtained in buffer solution are recalculated to thermodynamic pKTa which correspond to water medium3, 4).
All chemicals and solvents were of analytical-reagent grade. HEPES, MES, MOPSO, TAPS were purchased from Sigma-Aldrich (Steinheim, Germany). Sodium hydroxide, mesityl oxide and sodium acetate trihydrate from Fluka (Buchs, Switzerland). Acetic and formic acid from Lachema (Brno, Czech Republic). Studied substances (Table 1), with potential α- and β-adrenolytic properties, were synthesized by PharmDr. Matej Maruniak, PhD. at Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava5).
Experiments were carried out using an Agilent 3D CE system (Agilent Technologies, Waldbronn, Germany) equipped with a diode array detector. Results were enregistered by the system Agilent ChemStation and processed in the program SigmaPlot v. 10.0 (San Rafael, CA, USA). The pH values of used buffers were measured with a pH meter WTW InoLab pH Level 2 (Praha, Czech Republic) equipped with a combined electrode SenTix 41.
Electrophoretic measurements were performed in a fused-silica capillary of 48.5 cm total length, 40 cm effective length (from injection to detector) and 75 ∝m internal diameter. Before first using, capillary was rinsed with 0.1 mol.l–1 NaOH for 20 min, then with deionised water for 20 minutes. Between consecutive runs, the capillary was rinsed for 1 minute with 0.1 mol. l–1 NaOH solution, water and background electrolyte. When background electrolyte was changed, conditioning was extended to 15 min. The sample was injected by the pressure of 40 mbar for 4 s. A constant voltage of 15 kV was applied at 25 °C. Detection was at the wavelength of 254 nm.
Stock solution of 7.5.10–3 mol.l–1 of tested substances was prepared in deionised water. Concentration of mesityl oxide as the electroosmotic flow marker was 2.10–6 mol.l–1 in water. Working solutions were prepared by diluting the stock solution of analytes and mesityl oxide in each corresponding buffer to the final concentration of 7.5.10–4 mol.l–1 for analytes and 2.10–7 mol.l–1 for mesityl oxide.
Measurements were performed in the system of ten buffer solutions with a constant ionic strength 0.01 mol.l–1 within pH range of 4.5–8.5 (Table 2). Measurement of each compound in each of the background electrolytes was repeated four times. The online program Buffer Calculator was employed to calculate the composition of the series of background electrolytes with various pH6).
The effective electrophoretic mobilities ∝eff (m2V−-1s−-1) of analytes were calculated from observed migration times of each analyte and migration time of mesityl oxide according to the equation:
where Lt is the total length of the capillary (m), Ld is the effective length (m), U is the applied voltage (V), tmig the migration time of analyte (s) and tEOF the migration time of the electroosmotic flow marker (s)3, 4).
The sets of the experimentally obtained effective mobilities were fitted by the sigmoid curve, which is for the monoprotic weak base described by the equation:
where μBH+ is the ionic mobility of the fully protonated base. pKa of the compound is the pH in the inflexion point of the sigmoidal curve3, 4).
As the measurements are carried out in a system of buffer solutions of the ionic strength of 0.01 mol.l-1, the obtained values of pKa had to be converted to the thermodynamic dissociation constants (pKTa) which correspond to the aquatic environment of the zero ionic strength:
where for the calculation of the activity coefficients the following formula was used:
For the ionic strength of 0.01 mol.l–1 and a = 0,5 nm, logγ has a value of –0.04373, 4).
Results and discussion
Figure 1 shows an example of a typical experiment analysis. The injected mixture contained compound 5m1 and mesityl oxide, as the background electrolyte MOPSO (pH = 6,70) was used.
Measurements of each compound in each of the background electrolytes was repeated four times. The effective electrophoretic mobilities (m2V–1s–1) were calculated using the formula  where tmig is the migration time of the studied substance, whereas tEOF denotes the migration of mesityl oxide as the electroosmotic flow maker. pKa was determined using the dependence of the effective electrophoretic mobilities on the pH of the background electrolyte. This relationship was fitted in the program SigmaPlot v. 10.0 (San Rafael, CA, USA) by the sigmoidal mobility curve , where pKa is the value of pH in the sigmoid inflection point.
Dissociation constants obtained in buffer solvent were recalculated to the thermodynamic values (pKTa) for water medium of zero ionic strength [3, 4]. The mobility curve of the selected analyte is shown in Figure 2. The pKTa and values of individual compounds are given in Table 3.
The compounds under study were monohydrochlorides of weak bases. The pH range of background electrolyte solutions was chosen in order to guarantee practically full protonation (BH+) of analytes at the lowest pH and their no protonation (B) at the highest pH. We observed a decrease in the effective mobility with increasing pH. At the lowest pH the mobility of the analyte is maximal, which indicates the predominance of cationic species. As pH increases, a new species with zero electric charge is formed by deprotonation of the analyte and its effective mobility goes to zero. In the case of our molecules, we observed one inflexion point and the pKa of the compound is the pH in this inflexion point of the sigmoid curve.
One inflexion point in the mentioned pH range confirms that analytes are monohydrochlorides and have one pKa value. As assumed previously from their chemical structure, pKa corresponds to protonated piperazine nitrogen which is closer to the arylethanolamine chain. The pKa values of compounds do not refer about any evident influence of the chemical structure on the acidity of the molecule. Influence of pyridine-2-yl or pyrimidine-2-yl on the pKa of substances was not proven. Any important influence of R1 substituents (methyl–butyl) on pKa value was not observed, either.
Dissociation constants were determined for eight newly synthesized potential drugs. The pKa values of the compounds under study do not refer about any evident influence of the selected substituents on the acidity of the molecule. The results will be a help to a further study of the substances, first, the prediction of their pharmacokinetics and also in the optimization of the assay conditions of other physicochemical research.
An advantage of the capillary zone electrophoresis has been a need of a small quantity of the sample without the necessity of high purity, and the possibility to operate in an aqueous medium even in the case of low water solubility of studied substances.
This work was supported by the following grants: FaF UK/63/2015; FaF UK/28/2015; FaF UK/29/2015; FaF UK/44/2015; Grant UK/346/2015; Comenius University in Bratislava Science Park supported by the Research and Development Operational Programme funded by the ERDF – Grant number: ITMS 26240220086.
Conflicts of interest: none.
PharmDr. Iva Kapustíková, PhD.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava
Odbojárov 10, 832 32 Bratislava, Slovak Republic
1. Testa B., van de Waterbeemd H., Folkers G., Guy R. Pharmacokinetic optimization in drug research. Weinheim: Wiley-VCH 2001.
2. Babić S., Horvat A. J. M., Mutavdžić Pavlović D., Kaštelan-Macan M. Determination of pKa values of active pharmaceutical ingredients. Trends Anal. Chem. 2007; 26, 1043–1061.
3. Fuguet E., Reta M., Gibert C., Rosés M., Bosch E., Ràfols C. Critical evaluation of buffering solutions for pKa determination by capillary electrophoresis. Electrophoresis 2008, 29, 2841–2851.
4. Šlampová A., Křivánková L., Gebauer P., Boček P. J. Standard systems for measurement of pKa values and ionic mobilities 2. Univalent weak bases. J. Chromatogr. A 2009; 1216, 3637–3641.
5. Maruniak M. Preparation, physico-chemical properties and biological activity evaluation of cardiovascularactive potential drugs from the group of phenylcarbamic acid derivatives (Arylethanolamines, Aryloxyaminopropanols). Dissertation thesis. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava 2012.